Moderna Stock News

Moderna''s Covid-19 vaccine, Spikevax, has received full approval from the US Food and Drug Administration, according to news releases from the FDA and Moderna.

A vial of the Moderna COVID-19 vaccine is displayed on a counter at a pharmacy in Portland, Ore., Monday, Dec. 27, 2021. The FDA has full approved the Moderna COVID-19 vaccine. | Jenny Kane, Associated Press What did we learn about Moderna’s COVID-19 vaccine? The Food and Drug Administration Monday approved a second COVID-19 vaccine — the Moderna COVID-19 vaccine , which will be marketed as Spikevax. What happened: The FDA said Moderna’s vaccine, called Spikevac, met the “rigorous standards for safety, effectiveness and manufacturing quality required for approval.” The vaccine has been approved for emergency use authorization for those 18 years old and up. Quote: “The FDA’s approval of Spikevax is a significant step in the fight against the COVID-19 pandemic, marking the second vaccine approved to prevent COVID-19. The public can be assured that Spikevax meets the FDA’s high standards for safety, effectiveness and manufacturing quality required of any vaccine approved for use in the United States,” said Dr.

The Food and Drug Administration granted full approval to Moderna''s two-dose COVID-19 vaccine, marketed under the name Spikevax, more than a year after authorizing it for public use.

Rickards Slams Big Pharma''s Siege Of America Authored by James Rickards via DailyReckoning.com, Remember this time last year when the vax bandwagon really got rolling? The vax had been announced in November 2020 and was fast-tracked through the approval process (on an experimental basis at the time). But it took a while to get to doses shipped and distributed and for people to become aware of where they could get it. That played out over December 2020, but by January 2021, the effort was in full swing. The first thing those getting jabbed learned was they would have to return in a few weeks for the second dose. That was understood and widely accepted, although the Janssen vaccine is different and only requires one shot. Janssen is not nearly as available as the mRNA vaccines from Pfizer and Moderna. The bandwagon continued through 2021 to the point that about 70% of the U.S. population is now fully vaccinated. So Much for the Pandemic of the Unvaccinated But by September 2021, doubts arose about the efficacy of the vaccines.

Moderna Inc said on Monday it had received full approval from the US Food and Drug Administration (FDA) for its Covid-19 vaccine for individuals 18 years of age and older. The vaccine received an emergency use authorization in December 2020, and Moderna in August last year said it had completed…

"Irresponsible People Are Spreading Lies" - Joni Mitchell Removes Music From Spotify "In Solidarity" With Neil Young Another popular Canadian-born classic rock musician has decided to pull her music from Spotify in solidarity with Neil Young, whose label pulled his music from the streaming giant in protest over its deal with Joe Rogan. Popular folk musician Joni Mitchell - who, like Young, was in her hayday back in the 1970s but nevertheless maintains an audience among the young people of today (she''s particularly popular with a certain demographic: gay women) - announced her decision to pull her music from Spotify in a statement on her website. "Ive decided to remove all my music from Spotify. Irresponsible people are spreading lies that are costing people their lives. I stand in solidarity with Neil Young and the global scientific and medical communities on this issue," she said. As of Saturday morning in New York, most of Mitchell''s catalogue was still available on the app; Young''s had been removed earlier in the week after he sent the company a letter declaring that the service could have "Neil Young or Joe Rogan.

In solidarity with the selloff in the biotech space, Moderna (MRNA) has lost more than 41% YTD, becoming the sharpest decliner in the S&P 500, notwithstanding a promising

Even the CEOs of Pfizer and Moderna, who were leaning toward fourth doses, have eased off their rhetoric. The data just isn''t there, scientists say.

Public Health ''Experts'' Have A New COVID Boogeyman Called "Stealth" Omicron Deaths involving patients infected with COVID have risen in the US recently, even as case numbers have continued to decline. But what''s even more concerning is that a growing percentage of overall deaths are being attributed to ''breakthrough'' infections involving vaxxed & booster patients ). It''s just the latest example of how narratives pushed by the government change as they are confronted with contradictory evidence (this time, it''s the notion that the vaccinated would escape death, something we now know to be untrue). Despite this, it seems like people across the US and around the world are growing more bold as the longing t o return to "normal" intensifies. In northern Europe, Denmark and the Netherlands are abandoning COVID restrictions even as the outbreak has persisted. At the same time, scientists around the world have found something new with which to prime the public for Booster No. 4 (now that both Pfizer and Moderna have started human trials for their omicron-focused jabs): A new sub-variant called "stealth omicron", also known as BA.2.

You''re plenty aware by now that the major indexes are either flirting with or are actually in correction territory a drop of 10% or more from a peak. But if you take a closer look around, you''ll find individual equities that are much worse off. Indeed, the market is host to hundreds of crashing stocks at the moment. Interestingly, though, some of these falling knives might finally be ripe for catching. Many stocks down on their luck right now aren''t just getting caught in the stock market''s near-correction their woes are chalked up to actionable news items. SEE MORE The 22 Best Stocks to Buy for 2022 Moderna ( MRNA ), for instance, has lost just more than half its value over the past three months, retreating amid slowing vaccination rates. Intuitive Surgical ( ISRG ) recently announced Street-beating fourth-quarter results, sure, but investors appear to be put off by COVID taking a toll on the company''s robotic surgical procedures . But as the old Warren Buffett yarn says, "Be fearful when others are greedy, and greedy when others are fearful." Well, fear is here especially in a select group of stocks so it very well might be time to tap your inner greed.

IAVI , the nonprofit scientific research organization, and Moderna Inc (NASDAQ: MRNA ) have administered the first doses of experimental HIV vaccine antigens in a clinical trial. The Phase 1 trial, IAVI G002, is designed to test the hypothesis that sequential administration of priming … Full story available on Benzinga.com

Moderna (MRNA) and IAVI, a not-for-profit scientific research organization, announced that the dosing got underway in a clinical trial for the experimental HIV vaccine antigens…

Moderna Inc (NASDAQ: MRNA ) has started a mid-stage study, testing a booster dose of its COVID-19 vaccine specifically designed to target the omicron coronavirus variant . Additionally, Moderna announced the publication of neutralizing antibody data against the Omicron variant six months following a booster dose in The New England Journal of Medicine. The Company said that while the third shot of its original coronavirus vaccine increased neutralizing … Full story available on Benzinga.com

Moderna says it will study its Omicron-specific booster in adults aged 18 years and older.

British PM braces for partygate report as England scraps indoor mask requirements and vaccine passports; Moderna follows Pfizer in launching trial to target Omicron Tory MPs to send letters of no confidence in PM after partygate report Netherlands lifts toughest curbs, with France and Denmark to follow Coronavirus vaccines may reduce long Covid risks, study finds US donated 400m Covid vaccine doses to 112 countries, says White House Germany to crack down on Covid protesters in yellow star badges New Zealand braces for shift from Covid zero to Covid acceptance Hello and thanks for joining us for all the latest Covid developments this Thursday. Im Samantha Lock and Ill be here for the next hour or so before my colleague Martin Belam takes the reins from London. Continue reading